ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1670444
Nrf2 Activation by Celastrol in Nephrotoxicity Nrf2-Mediated Mechanistic Pathways of Celastrol Nephroprotection: Disrupting the Oxidative-Inflammatory-Apoptotic Axis in Cypermethrin Toxicity
Provisionally accepted
- College of Medicine, Taif University, Ta'if, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Cypermethrin, a widely used synthetic pyrethroid insecticide, accumulates in renal tissue causing kidney damage through incompletely understood mechanisms. This study evaluated celastrol's nephroprotective effect against cypermethrin-induced kidney injury in rats. Methods: Five groups of male Wistar rats (n=8 each) received daily treatments for 28 days: control, cypermethrin (25 mg/kg), celastrol (2 mg/kg), and celastrol+cypermethrin at low (1 mg/kg) or high (2 mg/kg) doses. Renal parameters, oxidative stress markers, inflammatory mediators, and apoptotic indicators were assessed using spectrophotometric assays, ELISA, qRT-PCR, and histology. Results: Cypermethrin impaired renal function, increased kidney weight, and elevated Kidney Injury Molecule-1 (KIM-1) levels. It significantly suppressed antioxidant defenses by reducing both the activities and mRNA expression of CAT, SOD, GPx, and GR, alongside GSH depletion and elevated oxidative markers (MDA, NO). Cypermethrin also downregulated the protein and gene expression of Nfe2l2, along with its downstream targets Hmox1, GCLC, and NQO1. Inflammatory responses were enhanced, as shown by upregulated TNF-α, IL-1β, NF-κB proteins and increased NOS2 expression. Apoptosis was induced through elevated Bax, cytochrome c, and caspase-3 protein and gene expression, while both Bcl-2 protein and Bcl2 mRNA were significantly reduced. Correlation analysis revealed significant inter-pathway connections, suggesting that oxidative stress as upstream trigger for inflammation and apoptosis. Celastrol treatment dose-dependently reversed these alterations, with the high dose restoring antioxidant and anti-apoptotic profiles more effectively than the low dose. Histopathological findings corroborated these results. Conclusion: Celastrol protects against cypermethrin nephrotoxicity through modulation of antioxidative, anti-inflammatory, and anti-apoptotic mechanisms. Correlation analysis suggests a potential role for Nrf2 in celastrol's integrated nephroprotective effects.
Keywords: Celastrol, oxidative, Cypermethrin, Apoptosis, antioxidant, Inflammation
Received: 21 Jul 2025; Accepted: 03 Sep 2025.
Copyright: © 2025 Albrakati. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ashraf Albrakati, College of Medicine, Taif University, Ta'if, Saudi Arabia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.